|Systematic (IUPAC) name|
|Legal status||Controlled (S8) (AU) ℞-only (CA) Schedule II (US)|
|Protein binding||> 95%|
|Mol. mass||352.47 g/mol|
|Melt. point||83 °C (181 °F)|
|(what is this?)|
Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s. It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.
Anileridine is no longer manufactured in the US or Canada.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|